The weekly litigation news digest is live. Subscribe now

IP Verse

Agents For Use In The Treatment Of Retinal Inflammation - EP3096781

The patent EP3096781 was granted to Centre National DE LA Recherche Scientifique Cnrs on Nov 2, 2022. The application was originally filed on Jan 22, 2015 under application number EP15701194A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3096781

CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS
Application Number
EP15701194A
Filing Date
Jan 22, 2015
Status
Granted And Under Opposition
Sep 30, 2022
Publication Date
Nov 2, 2022
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

STRAWMANAug 1, 2023D YOUNGADMISSIBLE

Patent Citations (8) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
EXAMINATIONEP1990060
EXAMINATIONUS2013195806
INTERNATIONAL-SEARCH-REPORTEP2116530
INTERNATIONAL-SEARCH-REPORTWO2004045507
OPPOSITIONWO2004045507
OPPOSITIONWO2007086490
OPPOSITIONWO2009014263
OPPOSITIONWO2009042677

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents